COVID A
UTHORS
Online profiles of coronavirus experts
Return to Top
Paolo Ascierto
Concepts (334)
Back to Profile
Concepts are derived automatically from a person's publications.
Cloud
Categories
Timeline
Details
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
3' Untranslated Regions
5'-Nucleotidase
Acute Lung Injury
Adenocarcinoma
Adenosine Monophosphate
Adjuvants, Immunologic
Administration, Intravenous
Administration, Oral
Adolescent
Adoptive Transfer
Adult
Adverse Drug Reaction Reporting Systems
Aged
Aged, 80 and over
Alanine Transaminase
Algorithms
Alternative Splicing
Anaphylaxis
Angiogenesis Inhibitors
Anilides
Animals
Antacids
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Viral
Antigen Presentation
Antigens, CD
Antigens, Neoplasm
Antineoplastic Agents
Antineoplastic Agents, Immunological
Antineoplastic Combined Chemotherapy Protocols
Antiviral Agents
Apoptosis
Arthralgia
Australia
Autoimmune Diseases
Azetidines
B7-H1 Antigen
Basal Cell Nevus Syndrome
Base Sequence
Benzimidazoles
Betacoronavirus
Binding Sites
Biomarkers
Biomarkers, Pharmacological
Biomarkers, Tumor
Biomedical Research
Blood Proteins
Blotting, Southern
Brain Neoplasms
Cadherins
Cancer Vaccines
Carbamates
Carcinogenesis
Carcinoma
Carcinoma, Basal Cell
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes
Celecoxib
Cell Cycle Checkpoints
Cell Line, Tumor
Cell Movement
Cell Proliferation
Cell Survival
Chemoembolization, Therapeutic
Chemotherapy, Adjuvant
China
Clinical Decision-Making
Clinical Trials as Topic
Clinical Trials, Phase II as Topic
Cohort Studies
Colitis
Combined Modality Therapy
Communicable Disease Control
Complement C5a
Congresses as Topic
Consensus Development Conferences as Topic
Coronavirus Infections
Creatine Kinase
Cross-Over Studies
CTLA-4 Antigen
Cyclooxygenase 2
Cytokines
Dacarbazine
Diarrhea
Diet
Disease Management
Disease Progression
Disease-Free Survival
DNA, Neoplasm
Dose-Response Relationship, Drug
Double-Blind Method
Down-Regulation
Drug Administration Schedule
Drug Approval
Drug Combinations
Drug Eruptions
Drug Interactions
Drug Monitoring
Drug Prescriptions
Drug Resistance, Neoplasm
Drug Substitution
Drug-Related Side Effects and Adverse Reactions
Drugs, Investigational
Dyspnea
Early Diagnosis
Electrochemotherapy
Electrophoresis, Agar Gel
Emotions
Endocrine System Diseases
Epithelial-Mesenchymal Transition
Esophageal Neoplasms
Esophagogastric Junction
Europe
Extracellular Signal-Regulated MAP Kinases
Eye Neoplasms
Fatigue
Female
Flow Cytometry
Follow-Up Studies
Gastrointestinal Diseases
Gastrointestinal Microbiome
Gene Expression
Gene Expression Regulation
Gene Expression Regulation, Neoplastic
Genetic Loci
Genetic Predisposition to Disease
Genomic Instability
Geography
GPI-Linked Proteins
Graft Rejection
Granulocyte-Macrophage Colony-Stimulating Factor
GTP Phosphohydrolases
Head and Neck Neoplasms
Health Care Costs
Health Services Accessibility
Hepatitis B, Chronic
Hepatitis C, Chronic
High-Throughput Nucleotide Sequencing
History, 20th Century
History, 21st Century
HIV Infections
Hospitalization
Host-Pathogen Interactions
Humans
Hypophysitis
Hypoxia
Imidazoles
Immunity
Immunoglobulin G
Immunoglobulin M
Immunohistochemistry
Immunologic Factors
Immunologic Memory
Immunomodulation
Immunophenotyping
Immunotherapy
In Situ Hybridization
Incidence
Indoles
Infection Control
Inflammation
Influenza A Virus, H1N1 Subtype
Influenza Pandemic, 1918-1919
Influenza, Human
Infusions, Intravenous
Injections, Intravenous
Intention to Treat Analysis
Interferon-alpha
Interferon-gamma
Interleukin-1
Interleukin-17
Interleukin-23
Interleukin-6
International Agencies
Internationality
Ipilimumab
Italy
Janus Kinases
Kaplan-Meier Estimate
Keratoacanthoma
Leukocyte Count
Leukocytes, Mononuclear
Limit of Detection
Liquid Biopsy
Liver Neoplasms
Logistic Models
Longitudinal Studies
Lung Neoplasms
Lymph Node Excision
Lymph Nodes
Lymphatic Metastasis
Lymphocyte Count
Lymphocytes
Lymphocytes, Tumor-Infiltrating
Macrophages
Male
MAP Kinase Kinase 1
MAP Kinase Kinase Kinases
MAP Kinase Signaling System
Maximum Tolerated Dose
Medical Oncology
Melanoma
Membrane Proteins
MicroRNAs
Microsatellite Repeats
Middle Aged
Mitogen-Activated Protein Kinase Kinases
Mitogen-Activated Protein Kinases
Models, Biological
Molecular Targeted Therapy
Monocytes
Mortality
Mouth Mucosa
Multicenter Studies as Topic
Mutation
Nanoparticles
Nasal Mucosa
Nausea
Neoadjuvant Therapy
Neoplasm Invasiveness
Neoplasm Metastasis
Neoplasm Proteins
Neoplasm Recurrence, Local
Neoplasm Staging
Neoplasm, Residual
Neoplasms
Neoplasms, Second Primary
Neoplastic Cells, Circulating
Neoplastic Stem Cells
Neutrophils
Nomograms
Noninvasive Ventilation
Nucleic Acids
Nutritional Status
Octamer Transcription Factor-3
Off-Label Use
Oncogene Addiction
Oncologists
Oximes
Pandemics
Patient Selection
Phenotype
Piperidines
Placebos
Pneumonia, Viral
Point-of-Care Systems
Poly(ADP-ribose) Polymerase Inhibitors
Polymorphism, Genetic
Postoperative Complications
Practice Patterns, Physicians'
Precision Medicine
Predictive Value of Tests
Prevalence
Prognosis
Programmed Cell Death 1 Receptor
Proportional Hazards Models
Prospective Studies
Protein Isoforms
Protein Kinase Inhibitors
Proteome
Proto-Oncogene Proteins B-raf
Proto-Oncogene Proteins c-mdm2
Pyridines
Pyridones
Pyrimidinones
Quality Assurance, Health Care
Quality of Life
Quinazolinones
Randomized Controlled Trials as Topic
Real-Time Polymerase Chain Reaction
Receptors, Formyl Peptide
Receptors, Interleukin-6
Recombinant Fusion Proteins
Recombinant Proteins
Reference Standards
Registries
Remission Induction
Reproducibility of Results
Response Evaluation Criteria in Solid Tumors
Retrospective Studies
Reverse Transcriptase Polymerase Chain Reaction
Risk Factors
RNA, Long Noncoding
RNA, Messenger
RNA, Untranslated
Sensitivity and Specificity
Severe Acute Respiratory Syndrome
Severity of Illness Index
Sex Characteristics
Signal Transduction
Skin Diseases
Skin Neoplasms
Small Cell Lung Carcinoma
Societies, Medical
Solubility
Spain
Spasm
Standard of Care
STAT Transcription Factors
Statistics as Topic
Stearoyl-CoA Desaturase
Sulfonamides
Surveys and Questionnaires
Survival Analysis
Survival Rate
Systems Biology
Tacrolimus Binding Proteins
Thy-1 Antigens
Time Factors
Time-to-Treatment
Tissue Distribution
T-Lymphocytes
Tomography, X-Ray Computed
Transfection
Transforming Growth Factor beta
Transplant Recipients
Treatment Outcome
Tumor Burden
Tumor Microenvironment
Tumor Necrosis Factor-alpha
United States
Up-Regulation
Urinary Bladder Neoplasms
Urokinase-Type Plasminogen Activator
Urothelium
Uveal Neoplasms
Validation Studies as Topic
Vimentin
Vomiting
Whole Exome Sequencing
Young Adult
Ascierto's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (334)
Derived automatically from this person's publications.
Melanoma
Proto-Oncogene Proteins B-raf
Skin Neoplasms
Immunotherapy
Antineoplastic Combined Chemotherapy Protocols
Explore
_
Co-Authors (360)
People in Profiles who have published with this person.
Botti, Gerardo
Ciliberto, Gennaro
Montesarchio, Vincenzo
Buonaguro, Franco
Giannarelli, Diana
Explore
_
Similar People (60)
People who share similar concepts with this person.
Argenziano, Giuseppe
Ribero, Simone
Zalaudek, Iris
Patrizi, Annalisa
Burki, Talha
Explore
_